PMC:7696151 / 19461-19730
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 526 | 172-175 | Chemical | denotes | HCQ | MESH:D006886 |
| 527 | 208-220 | Chemical | denotes | methotrexate | MESH:D008727 |
| 528 | 222-225 | Chemical | denotes | MTX | MESH:D008727 |
| 529 | 234-247 | Chemical | denotes | sulfasalazine | MESH:D012460 |
| 539 | 30-46 | Disease | denotes | CHIKV infections | MESH:D007239 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T139 | 0-269 | Sentence | denotes | Generally, the acute phase of CHIKV infections is treated with non-steroidal anti-inflammatory drugs (NSAIDs), while for the chronic persistent phase, treatments involving HCQ as monotherapy or combined with methotrexate (MTX) and/or sulfasalazine seem to be effective. |